Table 4. Estimated global burden of chronic pulmonary aspergillosis (CPA) after pulmonary tuberculosis (TB), by World Health Organization (WHO) region, for different rates of annual attrition (10–25%) and CPA frequency estimates^a.

CPA frequency		Global			Europe			Africa			Eastern Mediterranean			Americas			Western Pacific			South-East Asia
TB cavity	No TB cavity	10%	15%	25%	10%	15%	25%	10%	15%	25%	10%	15%	25%	10%	15%	25%	10%	15%	25%	10%	15%	25%
30%	4%	2 088 604	1 786 412	1 296 646	68 111	58 256	42 284	551 639	471 825	342 469	115 395	98 699	71 639	70 584	60 371	43 820	469 154	401 274	291 260	813 721	695 987	505 174
22%	4%	1 713 570	1 465 640	1 063 817	58 927	56 401	36 583	451 754	386 392	280 458	94 500	80 828	58 668	57 803	49 440	35 885	384 204	328 615	238 522	666 381	569 965	413 702
22%	2%	1 372 457	1 173 881	852 048	42 091	36 001	26 131	363 219	310 667	225 494	75 980	64 987	47 170	46 475	39 751	28 852	308 908	264 213	191 776	535 783	458 263	332 625
22%	1%	1 201 900	1 028 002	746 163	33 673	28 801	20 905	318 952	272 804	198 012	66 720	57 067	41 421	40 811	34 906	25 336	271 260	232 012	168 403	470 485	402 412	292 086
10%	1%	639 349	546 844	396 920	19 898	17 019	12 353	169 124	144 654	104 995	35 378	30 260	21 964	21 640	18 509	13 434	143 835	123 024	89 296	249 474	213 379	154 878

^a Estimated frequency was 10–30% in patients with cavities and 1–4% in patients without cavities after completion of anti-tuberculous therapy.